Your browser does not support JavaScript!
COVID-19 : Découvrez les Plans de Continuité d’Activité des entreprises de la biotechnologies
Logo de Labiotech.eu

Labiotech.eu Source d'actualité

Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 semaines
Why New Antifungals Are Desperately Needed
Serious systemic fungal infections are rare, but with antimicrobial resistance on the rise and only a limited number of approved drugs available, it is imperative that new treatment options are...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 semaines
Llama-Derived Nanobodies Join the Fight Against Covid-19
Newly-launched Belgian startup ExeVir Bio will develop ‘nanobodies’ that bind very precisely to key areas of the Covid-19 virus and other coronaviruses after raking in €23M in Series A. Based in...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 semaines
Current and Emerging Therapeutic Approaches for Autoimmune Diseases
Over 4% of the world’s population suffers from one or more of over 80 autoimmune diseases identified to date. A large variety of treatment approaches has already been developed to curb the detrimental...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 semaines
Medical Cannabis: Regulatory Issues, Patient Demand, and Pricing Changes in Germany
While the coronavirus pandemic has shaken many industries to their core, the European medical cannabis industry continues to flourish. A number of recent developments in Germany show that the demand...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 semaines
Update: DNA Script Raises €80M to Bring Rapid DNA Synthesis to the Lab
Update on 29/07/2020: DNA Script has increased the total raised in its Series B round to €80M ($89M). The additional funds will support the commercial launch of the company’s benchtop DNA printer,...
www.labiotech.eu
Charger plus d'actualités

Informations juridiques
SIREN / SIRET - DE Labiotech

Adresse
Berlin Berlin DE Allemagne